Estrogen Receptor Beta (ERβ) Expression in Colorectal Cancer (CRC)—A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 29.07.2026 · 15 (15) · 5924
DOI: 10.3390/jcm15155924 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.07.2026. Verfasst von Yael Sher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Adelson Faculty of Medicine, Ariel University, Ariel 40700, Israel. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
ERβ is an estrogen receptor isoform expressed in the normal human colon and has been proposed to act as a tumor suppressor gene. The loss of ERβ expression has been associated with advanced stages of CRC. The aim was to investigate the relationship between ERβ expression and CRC progression, quantifying the difference between tumor tissues and normal controls, and early-stage versus late-stage tumors.
Methods
English Medical literature searches were conducted using PubMed, Embase, and Google Scholar up to 31 December 2025 according to PRISMA. Case–control studies comparing ERβ expression in CRC biopsy specimens with that in healthy controls were included. A meta-analysis was performed using Comprehensive Meta-analysis (Version 4). Pooled ORs and 95% confidence intervals were calculated using a random-effects model. Heterogeneity was assessed using the Cochrane Q test and the I2 statistic. Publication bias was evaluated.
Results
Six studies, representing 13 sub-studies, were selected according to the inclusion criteria, involving 1183 patients and 1000 normal mucosa/tumor early-stage patients. The OR for ERβ expression was 0.211 (95%CI: 0.122–0.363), significantly lower in advanced tumor stages than in normal mucosa and early tumor stages (p < 0.0001). Positivity rates were 76.40% in controls and early-stage tumor patients versus 51.31% in tumor patients (all stages). Heterogeneity was high (I2 = 78%), but sensitivity analysis confirmed the robustness of the results. Publication bias was not significant. The studies used different methods and positivity cut-off values, with high heterogeneity, and were from only five countries, indicating the possibility of variation in results across other geographical areas or ethnic groups.
Conclusions
ERβ expression is significantly lower in CRC tissues than in healthy controls and progressively decreases as the disease progresses. This finding underscores ERβ’s potential role as a prognostic factor and highlights the viability of ERβ activation as a novel therapeutic strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adelson Faculty of Medicine, Ariel University, Ariel 40700, Israel.
Zitieren
APA
Sher, Y., & Niv, Y. (2026). Estrogen Receptor Beta (ERβ) Expression in Colorectal Cancer (CRC)—A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 15(15), 5924. https://doi.org/10.3390/jcm15155924
Vancouver
Sher Y, Niv Y. Estrogen Receptor Beta (ERβ) Expression in Colorectal Cancer (CRC)—A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2026;15(15):5924. doi:10.3390/jcm15155924
BibTeX
@article{Sher2026,
author = {Sher, Yael and Niv, Yaron},
title = {Estrogen Receptor Beta (ERβ) Expression in Colorectal Cancer (CRC)—A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5924},
doi = {10.3390/jcm15155924}
}
EUVIMED